mechanism of action of glp-1 receptor agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review GLP-1 Receptor Agonists Explained for
Description
As mentioned by Lingvay et al., semaglutide has shown promise as a treatment option for non-diabetics with established atherosclerotic disease by reducing their risk of MACE by 20% despite having varying HBA1c baselines [47]
doi: 10.3389/fnins.2022.970925
however, the increase is not reciprocated in the blood supply [52]
January 2026
Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
